Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Media Coverage of the Benefits and Harms of Testing the Healthy: a protocol for a descriptive study.

O'Keeffe M, Barratt A, Maher C, Zadro J, Fabbri A, Jones M, Moynihan R.

BMJ Open. 2019 Aug 24;9(8):e029532. doi: 10.1136/bmjopen-2019-029532.

2.

Resisting recommended treatment for prostate cancer: a qualitative analysis of the lived experience of possible overdiagnosis.

McCaffery K, Nickel B, Pickles K, Moynihan R, Kramer B, Barratt A, Hersch J.

BMJ Open. 2019 May 23;9(5):e026960. doi: 10.1136/bmjopen-2018-026960.

3.

Australia is responding to the complex challenge of overdiagnosis.

Moynihan R, Barratt AL, Glasziou PP.

Med J Aust. 2019 Jun;210(11):525-525.e1. doi: 10.5694/mja2.50197. Epub 2019 May 22. No abstract available.

PMID:
31119741
4.

Commercial interests, transparency, and independence: a call for submissions.

Moynihan R, Macdonald H, Heneghan C, Bero L, Godlee F.

BMJ. 2019 Apr 16;365:l1706. doi: 10.1136/bmj.l1706. No abstract available.

PMID:
30992258
5.

Reforming disease definitions: a new primary care led, people-centred approach.

Moynihan R, Brodersen J, Heath I, Johansson M, Kuehlein T, Minué-Lorenzo S, Petursson H, Pizzanelli M, Reventlow S, Sigurdsson J, Stavdal A, Treadwell J, Glasziou P.

BMJ Evid Based Med. 2019 Oct;24(5):170-173. doi: 10.1136/bmjebm-2018-111148. Epub 2019 Apr 8. No abstract available.

PMID:
30962252
6.

Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories.

Moynihan R, Lai A, Jarvis H, Duggan G, Goodrick S, Beller E, Bero L.

BMJ Open. 2019 Feb 5;9(2):e025864. doi: 10.1136/bmjopen-2018-025864.

7.

Public perceptions of changing the terminology for low-risk thyroid cancer: a qualitative focus group study.

Nickel B, Semsarian C, Moynihan R, Barratt A, Jordan S, McLeod D, Brito JP, McCaffery K.

BMJ Open. 2019 Feb 5;9(2):e025820. doi: 10.1136/bmjopen-2018-025820.

8.

Media Coverage of the Benefits and Harms of the 2017 Expanded Definition of High Blood Pressure.

Moynihan RN, Clark J, Albarqouni L.

JAMA Intern Med. 2019 Feb 1;179(2):272-273. doi: 10.1001/jamainternmed.2018.6201. No abstract available.

PMID:
30592488
9.

Effect of a Change in Papillary Thyroid Cancer Terminology on Anxiety Levels and Treatment Preferences: A Randomized Crossover Trial.

Nickel B, Barratt A, McGeechan K, Brito JP, Moynihan R, Howard K, McCaffery K.

JAMA Otolaryngol Head Neck Surg. 2018 Oct 1;144(10):867-874. doi: 10.1001/jamaoto.2018.1272.

10.

Australia is responding to the complex challenge of overdiagnosis.

Moynihan R, Barratt AL, Buchbinder R, Carter SM, Dakin T, Donovan J, Elshaug AG, Glasziou PP, Maher CG, McCaffery KJ, Scott IA.

Med J Aust. 2018 Oct 15;209(8):332-334. No abstract available.

PMID:
30309305
11.

Association of Preferences for Papillary Thyroid Cancer Treatment With Disease Terminology: A Discrete Choice Experiment.

Nickel B, Howard K, Brito JP, Barratt A, Moynihan R, McCaffery K.

JAMA Otolaryngol Head Neck Surg. 2018 Oct 1;144(10):887-896. doi: 10.1001/jamaoto.2018.1694.

12.

Renaming low risk conditions labelled as cancer.

Nickel B, Moynihan R, Barratt A, Brito JP, McCaffery K.

BMJ. 2018 Aug 12;362:k3322. doi: 10.1136/bmj.k3322. No abstract available.

PMID:
30100549
13.

Patients' experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study.

Nickel B, Brito JP, Moynihan R, Barratt A, Jordan S, McCaffery K.

BMC Cancer. 2018 Mar 2;18(1):242. doi: 10.1186/s12885-018-4152-9.

14.

Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study.

Mintzes B, Swandari S, Fabbri A, Grundy Q, Moynihan R, Bero L.

BMJ Open. 2018 Feb 13;8(2):e019027. doi: 10.1136/bmjopen-2017-019027.

15.

Evidence-Informed Health Policy: Using Research to Make Health Systems Healthier [Internet].

Moynihan R, Oxman AD, Lavis JN, Paulsen E.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2008 Jan.

16.

The Christmas gift of genetic uncertainty.

Semsarian C, Moynihan R.

BMJ. 2017 Dec 22;359:j5762. doi: 10.1136/bmj.j5762. No abstract available.

PMID:
29273693
17.

Mapping the drivers of overdiagnosis to potential solutions.

Pathirana T, Clark J, Moynihan R.

BMJ. 2017 Aug 16;358:j3879. doi: 10.1136/bmj.j3879. No abstract available.

PMID:
28814436
18.

Words do matter: a systematic review on how different terminology for the same condition influences management preferences.

Nickel B, Barratt A, Copp T, Moynihan R, McCaffery K.

BMJ Open. 2017 Jul 10;7(7):e014129. doi: 10.1136/bmjopen-2016-014129. Review.

19.

A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.

Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA.

BMJ Open. 2017 Jun 30;7(6):e016701. doi: 10.1136/bmjopen-2017-016701.

20.

Wise choices: making physiotherapy care more valuable.

Traeger AC, Moynihan RN, Maher CG.

J Physiother. 2017 Apr;63(2):63-65. doi: 10.1016/j.jphys.2017.02.003. Epub 2017 Feb 28. No abstract available.

21.

Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.

Nickel B, Brito JP, Barratt A, Jordan S, Moynihan R, McCaffery K.

Thyroid. 2017 May;27(5):661-671. doi: 10.1089/thy.2016.0483. Epub 2017 Mar 21.

PMID:
28322617
22.

Communicating about overdiagnosis: Learning from community focus groups on osteoporosis.

Moynihan R, Sims R, Hersch J, Thomas R, Glasziou P, McCaffery K.

PLoS One. 2017 Feb 3;12(2):e0170142. doi: 10.1371/journal.pone.0170142. eCollection 2017.

23.

Toward a Healthier Patient Voice: More Independence, Less Industry Funding.

Moynihan R, Bero L.

JAMA Intern Med. 2017 Mar 1;177(3):350-351. doi: 10.1001/jamainternmed.2016.9179. No abstract available.

PMID:
28114596
24.

Improving coverage of medical research in a changing media environment.

Medew J, Moynihan R.

CMAJ. 2017 Apr 18;189(15):E551-E552. doi: 10.1503/cmaj.161206. Epub 2016 Dec 19. No abstract available.

25.

Authors' reply to Timms and Bird.

Johansson M, Jørgensen KJ, Getz L, Moynihan R.

BMJ. 2016 Aug 15;354:i4362. doi: 10.1136/bmj.i4362. No abstract available.

PMID:
27528539
26.

Caution! Diagnosis creep.

Moynihan R.

Aust Prescr. 2016 Apr;39(2):30-1. doi: 10.18773/austprescr.2016.021. Epub 2016 Apr 1. No abstract available.

27.

"Informed choice" in a time of too much medicine-no panacea for ethical difficulties.

Johansson M, Jørgensen KJ, Getz L, Moynihan R.

BMJ. 2016 May 9;353:i2230. doi: 10.1136/bmj.i2230. No abstract available.

PMID:
27160274
28.

Walking the tightrope: communicating overdiagnosis in modern healthcare.

McCaffery KJ, Jansen J, Scherer LD, Thornton H, Hersch J, Carter SM, Barratt A, Sheridan S, Moynihan R, Waller J, Brodersen J, Pickles K, Edwards A.

BMJ. 2016 Feb 5;352:i348. doi: 10.1136/bmj.i348. No abstract available.

PMID:
26850726
29.

How different terminology for ductal carcinoma in situ impacts women's concern and treatment preferences: a randomised comparison within a national community survey.

McCaffery K, Nickel B, Moynihan R, Hersch J, Teixeira-Pinto A, Irwig L, Barratt A.

BMJ Open. 2015 Nov 2;5(11):e008094. doi: 10.1136/bmjopen-2015-008094.

30.

How different terminology for ductal carcinoma in situ (DCIS) impacts women's concern and management preferences: A qualitative study.

Nickel B, Barratt A, Hersch J, Moynihan R, Irwig L, McCaffery K.

Breast. 2015 Oct;24(5):673-9. doi: 10.1016/j.breast.2015.08.004. Epub 2015 Sep 12.

PMID:
26376460
31.

Public Opinions about Overdiagnosis: A National Community Survey.

Moynihan R, Nickel B, Hersch J, Beller E, Doust J, Compton S, Barratt A, Bero L, McCaffery K.

PLoS One. 2015 May 20;10(5):e0125165. doi: 10.1371/journal.pone.0125165. eCollection 2015.

32.

What do you think overdiagnosis means? A qualitative analysis of responses from a national community survey of Australians.

Moynihan R, Nickel B, Hersch J, Doust J, Barratt A, Beller E, McCaffery K.

BMJ Open. 2015 May 19;5(5):e007436. doi: 10.1136/bmjopen-2014-007436.

33.

Preventing overdiagnosis: the myth, the music, and the medical meeting.

Moynihan R.

BMJ. 2015 Mar 18;350:h1370. doi: 10.1136/bmj.h1370. No abstract available.

PMID:
25787718
34.

Evening the score on sex drugs: feminist movement or marketing masquerade?

Moynihan R.

BMJ. 2014 Oct 17;349:g6246. doi: 10.1136/bmj.g6246. No abstract available.

PMID:
25354348
35.

Using evidence to combat overdiagnosis and overtreatment: evaluating treatments, tests, and disease definitions in the time of too much.

Moynihan R, Henry D, Moons KG.

PLoS Med. 2014 Jul 1;11(7):e1001655. doi: 10.1371/journal.pmed.1001655. eCollection 2014 Jul. No abstract available.

36.

Was the flu drug zanamivir a breakthrough or money for old rope?

Moynihan R.

BMJ. 2014 Jun 2;348:g3611. doi: 10.1136/bmj.g3611. No abstract available.

PMID:
24891329
37.

Privacy is theft--sharing is caring.

Moynihan R.

BMJ. 2014 Feb 5;348:g1320. doi: 10.1136/bmj.g1320. No abstract available.

PMID:
24501253
38.

Too much medicine: from evidence to action.

Moynihan R, Heneghan C, Godlee F.

BMJ. 2013 Dec 4;347:f7141. doi: 10.1136/bmj.f7141. No abstract available.

PMID:
24307723
39.

Act now to fight chronic procrastination disorder.

Moynihan R.

BMJ. 2013 Oct 28;347:f6119. doi: 10.1136/bmj.f6119. No abstract available.

PMID:
24167202
40.

Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States.

Moynihan RN, Cooke GP, Doust JA, Bero L, Hill S, Glasziou PP.

PLoS Med. 2013 Aug;10(8):e1001500. doi: 10.1371/journal.pmed.1001500. Epub 2013 Aug 13.

41.

Science of overdiagnosis to be served up with a good dose of humility.

Moynihan R.

BMJ. 2013 Aug 20;347:f5157. doi: 10.1136/bmj.f5157. No abstract available.

PMID:
23963561
42.

Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased.

Moynihan R, Glassock R, Doust J.

BMJ. 2013 Jul 29;347:f4298. doi: 10.1136/bmj.f4298. No abstract available.

PMID:
23900313
43.

Too much medicine; too little care.

Glasziou P, Moynihan R, Richards T, Godlee F.

BMJ. 2013 Jul 2;347:f4247. doi: 10.1136/bmj.f4247. No abstract available.

PMID:
23820022
44.

Australia moves closer to full disclosure of drug company payments to doctors.

Moynihan R.

BMJ. 2013 Jun 19;346:f3960. doi: 10.1136/bmj.f3960. No abstract available.

PMID:
23783360
45.

Classification accuracy of serum Apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan.

Bazarian JJ, Blyth BJ, He H, Mookerjee S, Jones C, Kiechle K, Moynihan R, Wojcik SM, Grant WD, Secreti LM, Triner W, Moscati R, Leinhart A, Ellis GL, Khan J.

J Neurotrauma. 2013 Oct 15;30(20):1747-54. doi: 10.1089/neu.2013.2853. Epub 2013 Aug 24.

46.

The future of medicine lies in truly shared decision making.

Moynihan R.

BMJ. 2013 May 14;346:f2789. doi: 10.1136/bmj.f2789. No abstract available.

PMID:
23674138
47.

Winding back the harms of too much medicine.

Moynihan R, Glasziou P, Woloshin S, Schwartz L, Santa J, Godlee F.

BMJ. 2013 Feb 26;346:f1271. doi: 10.1136/bmj.f1271. No abstract available.

PMID:
23444422
48.

What is disease? And why it's a healthy question.

Moynihan R.

BMJ. 2013 Jan 9;346:f107. doi: 10.1136/bmj.f107. No abstract available.

PMID:
23303894
49.

Too much medicine, not enough mirth.

Moynihan R.

BMJ. 2012 Oct 31;345:e7116. doi: 10.1136/bmj.e7116. No abstract available.

PMID:
23114064
50.

e-Health records: beware of assumed benefit.

Moynihan RN.

Med J Aust. 2012 Sep 17;197(6):319. No abstract available.

PMID:
22994812

Supplemental Content

Loading ...
Support Center